(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MÉTODOS PARA TRATAR CÂNCER COLORRETAL USANDO UM ANTICORPO ANTI-CTLA4

Em AnáliseInvention PatentPCT · US2023036433

Application data

Number

112025008340

Type

Invention Patent

Filing

10/31/2023

Publication

12/02/2025

PCT

US2023036433

Progress at the INPI

Examination not yet requested
  1. Filing10/31/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 10/31/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:10/31/2026(67 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/02/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AGENUS INC.

US

See this company's full portfolio

Inventors

D. C. (pessoa física)

US

J. G. (pessoa física)

US

S. O. (pessoa física)

US

Technical data

Priority claims

US

63/381,621 · 10/31/2022

US

63/497,392 · 04/20/2023

Abstract

São fornecidos métodos para tratar câncer colorretal com um anticorpo que se liga especificamente ao Antígeno 4 do Linfócito T Citotóxico Humano (CTLA-4).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

12/02/2025

RPI 2865

Alteração de dados cadastrais

#1.1

06/10/2025

RPI 2840

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.